混合性结缔组织病中的抗SMN自身抗体与严重系统性硬化表型相关
回顾性混合性结缔组织病队列纳入66例患者,采用可寻址激光珠免疫分析法检测抗SMN自身抗体,比较抗SMN阳性与阴性亚组的临床特征。抗SMN阳性者指尖凹陷性瘢痕、下消化道受累和心肌炎频率更高,高滴度阳性者联合结局的校正OR为7.79。
要点
- 66例混合性结缔组织病患者中39例(59%)抗SMN阳性,其中高滴度29例(74%)。
- 抗SMN阳性组指尖凹陷性瘢痕23% vs 阴性组4%,下消化道受累26% vs 4%,心肌炎16% vs 0%。
- 高滴度抗SMN阳性者联合结局校正OR 7.79(2.33至30.45,p=0.002)。
核心结论
- 抗SMN自身抗体存在于本混合性结缔组织病队列的59%患者中,尤其高滴度阳性与包括肌炎、心肌炎和下消化道受累的严重系统性硬化表型相关。
研究设计与样本
- 回顾性混合性结缔组织病队列研究,共纳入66例患者,采用可寻址激光珠免疫分析法检测抗SMN自身抗体,以平均荧光强度<300为正常参考范围、300-999为低滴度阳性、≥1000为高滴度阳性。
主要发现
- 混合性结缔组织病诊断时中位年龄40.6岁,随访时长12年。
- 基于最高可得滴度,39例(59%)为抗SMN阳性,其中10例(26%)为低滴度、29例(74%)为高滴度。
- 抗SMN阳性组与阴性组比较:指尖凹陷性瘢痕23% vs 4%(p=0.04),下消化道受累26% vs 4%(p=0.04),心肌炎16% vs 0%(p=0.04)。
- 指尖凹陷性瘢痕和/或下消化道受累和/或肌炎和/或心肌炎的联合结局在高滴度抗SMN阳性患者中最高,校正OR 7.79(2.33至30.45,p=0.002)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The survival of motor neuron (SMN) complex has an essential role in the assembly of small nuclear ribonucleoproteins (RNP). Recent reports have described autoantibodies (aAbs) to the SMN complex as novel biomarkers in anti-U1RNP+ myositis patients. The aim of this study was to compare phenotypic features of anti-U1RNP+ mixed connective tissue disease (MCTD) patients with and without anti-SMN aAbs. METHODS: A retrospective MCTD cohort was studied. Addressable laser bead immunoassay was used to detect specific anti-SMN aAbs with <300 mean fluorescence intensity (MFI) as normal reference range, 300-999 MFI as low-titre and ≥1000 MFI as high-titre positivity. Comparison of clinical features between anti-SMN+ and anti-SMN- subgroups used two-tailed Fisher's exact test, and logistic regression analyses. RESULTS: Sixty-six patients were included. Median age at MCTD diagnosis was 40.6 years, and duration of follow-up was 12 years. Based on the highest available titre, 39 (59%) were anti-SMN+: 10 (26%) had low titre and 29 (74%) had high titre. Anti-SMN+ patients had a higher frequency of fingertip pitting scars (anti-SMN+ 23% vs anti-SMN- 4%, p=0.04), lower gastrointestinal (GI) involvement (26% vs 4%, p=0.04), and myocarditis (16% vs 0%, p=0.04). The combined outcome of pitting scars and/or lower GI involvement and/or myositis and/or myocarditis was highest among high-titre anti-SMN+ patients: adjusted OR 7.79 (2.33 to 30.45, p=0.002). CONCLUSIONS: Anti-SMN aAbs were present in 59% of our MCTD cohort. Their presence, especially at high-titres, was associated with a severe systemic sclerosis (scleroderma) phenotype including myositis, myocarditis and lower GI involvement.
引用
- El Kamouni H, S Jalaledin D, Albert A, et al. Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype. RMD Open. 2023. PMID: 37797966. doi:10.1136/rmdopen-2023-003431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。